Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that in compliance with the Company’s Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons of the Company (along with his/her immediate relatives or any person with whom he/she shares a material financial relationship), shall be with effect from Saturday, October 1, 2022 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. The date of the Board Meeting of the Company for declaration of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE.